CSPCHA131 + chemotherapy

CSPCHA131 + chemotherapy is an investigational combination therapy used in clinical trials for patients with advanced solid tumors. CSPCHA131 is a novel drug candidate—mechanism of action not explicitly described in public summaries—administered either as monotherapy or in combination with standard chemotherapy regimens. In ongoing clinical trials, this combination is being evaluated for its safety, tolerability, and preliminary efficacy in advanced cancer patients who are often ineligible for standard treatment or who have relapsed/refractory disease[1][9]. The chemotherapy component is not specified in available sources and likely consists of standard regimens appropriate for the tumor type in the trial setting.